GM pigs one step closer to providing organs for human transplant

US scientists are the closest yet to creating genetically modified pigs with organs that can be safely transplanted into humans.

The researchers identified and eliminated 25 porcine endogenous retroviruses (PERVS) hidden in the pigs’ DNA that can trigger organs to be rejected by the human immune system, thereby overcoming one of the biggest barriers in interspecies transplant or “xenotransplantation.”

Our study highlighted the value of PERV inactivation to prevent cross-species viral transmission and demonstrated the successful production of PERV-inactivated animals to address the safety concern in clinical xenotransplantation,”

Luhan Yang (Harvard university) and colleagues.

The researchers say preventing the rejection of pig organs is a huge challenge, but that these pigs are the most genetically modified animals far. If xenotransplantation can be made safe, it has the potential to prevent the thousands of people in need of transplants having to wait so long to receive an organ.

As reported in Science, the team used the gene-editing technology CRISPR to eliminate the viruses in 37 pigs. This game-changing technology involves a piece of “guide RNA” binding to a sequence of viral DNA and then guiding an enzyme to cut it at specific sites, so that DNA parts can be removed or added.

Next, using the same cloning technology that created Dolly the sheep, the researchers inserted the modified genetic material into pigs’ eggs to create embryos, which resulted in the birth of 37 healthy piglets.

This work provides a promising first step in the development of genetic strategies for creating strains of pigs where the risk of transmission of retroviruses has been eliminated. It remains to be seen whether these results can be translated into a fully safe strategy in organ transplantation."

Ian McConnell (University of Cambridge)

Removing the viruses is only part of the challenge in preventing organ rejection; even the transplant of human organs triggers adverse immune reactions that lead to rejection.

The eGenesis team are currently looking at further genetic modifications that can be made to increase the suitability of the organs for the human immune system.

Sources

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). GM pigs one step closer to providing organs for human transplant. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20170814/GM-pigs-one-step-closer-to-providing-organs-for-human-transplant.aspx.

  • MLA

    Robertson, Sally. "GM pigs one step closer to providing organs for human transplant". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20170814/GM-pigs-one-step-closer-to-providing-organs-for-human-transplant.aspx>.

  • Chicago

    Robertson, Sally. "GM pigs one step closer to providing organs for human transplant". News-Medical. https://www.news-medical.net/news/20170814/GM-pigs-one-step-closer-to-providing-organs-for-human-transplant.aspx. (accessed November 22, 2024).

  • Harvard

    Robertson, Sally. 2018. GM pigs one step closer to providing organs for human transplant. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20170814/GM-pigs-one-step-closer-to-providing-organs-for-human-transplant.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study identifies a potential treatment for Sandhoff and Tay-Sachs diseases